Contents

Current Vascular Pharmacology, Volume 16 - Number 3

Biography   Open Access

Meet Our Editorial Board Member

, 16(3): 205

Aurelio Leone


DOI: 10.2174/157016111603180326112112




Editorial   Open Access

Editorial: Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis: An Epidemic that will Boost the Incidence of Cardiovascular Morbidity and Mortality

, 16(3): 206 - 208

Vasilios G. Athyros and Michael Doumas


DOI: 10.2174/157016111603180326112541




Review Article

NAFLD-NASH: An Under-Recognized Epidemic

, 16(3): 209 - 213

Joseph Jennings, Charles Faselis and Michael D. Yao*


DOI: 10.2174/1570161115666170622074007





Review Article

Nonalcoholic Fatty Liver Disease vs. Nonalcoholic Steatohepatitis: Pathological and Clinical Implications

, 16(3): 214 - 218

Chrysoula Boutari*, Petros Lefkos, Vasilios G. Athyros, Asterios Karagiannis and Konstantinos Tziomalos


DOI: 10.2174/1570161115666170621075157





Review Article

Is Nonalcoholic Fatty Liver Disease Indeed the Hepatic Manifestation of Metabolic Syndrome?

, 16(3): 219 - 227

Niki Katsiki, Pablo Perez-Martinez, Panagiotis Anagnostis, Dimitri P. Mikhailidis* and Asterios Karagiannis


DOI: 10.2174/1570161115666170621075619





Review Article

A Critical Approach of Guideline Therapeutic Recommendations for NAFLD

, 16(3): 228 - 238

Dragan B. Djordjevic, Marija Zdravkovic, Aleksandar Nagorni, Athanasios Manolis, Costas Tsioufis and Dragan Lovic*


DOI: 10.2174/1570161115666170621080228





Review Article

Lifestyle Modifications in Non-Alcoholic Fatty Liver Disease and Non- Alcoholic Steatohepatitis

, 16(3): 239 - 245

Konstantinos Stavropoulos, Konstantinos Imprialos, Andreas Pittaras, Charles Faselis, Puneet Narayan and Peter Kokkinos*


DOI: 10.2174/1570161115666170621080835





Review Article

Statins: An Under-Appreciated Asset for the Prevention and the Treatment of NAFLD or NASH and the Related Cardiovascular Risk

, 16(3): 246 - 253

Vasilios G. Athyros*, Chrysa Boutari, Konstantinos Stavropoulos, Panagiotis Anagnostis, Konstantinos P. Imprialos, Michael Doumas and Asterios Karagiannis


DOI: 10.2174/1570161115666170621082910





Review Article

The Co-Existence of NASH and Chronic Kidney Disease Boosts Cardiovascular Risk: Are there any Common Therapeutic Options?

, 16(3): 254 - 268

Marianna Papademetriou, Vasilios G. Athyros, Eleni Geladari, Michael Doumas, Costas Tsioufis and Vasilios Papademetriou*


DOI: 10.2174/1570161115666170621081638





Review Article

Can Serum Uric Acid Lowering Therapy Contribute to the Prevention or Treatment of Nonalcoholic Fatty Liver Disease?

, 16(3): 269 - 275

Paschalis Paschos, Vasilios G. Athyros, Achilleas Tsimperidis, Anastasia Katsoula, Nikolaos Grammatikos and Olga Giouleme*


DOI: 10.2174/1570161115666170621082237





Review Article

Current and Potential Future Pharmacological Approaches for Non- Alcoholic Fatty Liver Disease

, 16(3): 276 - 288

Konstantinos Imprialos, Konstantinos Stavropoulos, Sofia Bouloukou, Georgios Kerpiniotis, Asterios Karagiannis and Michael Doumas*


DOI: 10.2174/1570161115666170621083744





Research Article

Vitamin D Levels in Middle-Aged Patients with Obstructive Sleep Apnoea Syndrome

, 16(3): 289 - 297

K. Archontogeorgis, E. Nena, N. Papanas, A. Zissimopoulos, A. Voulgaris, M. Xanthoudaki, V. Manolopoulos, M. Froudarakis and P. Steiropoulos*


DOI: 10.2174/1570161115666170529085708





Research Article

Lipid Metabolism in Patients with End-Stage Renal Disease: A Five Year Follow-up Study

, 16(3): 298 - 305

Magdalena Dusejovska, Barbora Stankova, Marek Vecka*, Jana Rychlíkova, Magdalena Mokrejsova, Ivan Rychlík and Ales Zak


DOI: 10.2174/1570161115666170530104143





Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science